LON:EVG - Evgen Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 15.65 -1.10 (-6.57 %)
(As of 02/21/2019 04:00 PM ET)
Previous CloseGBX 16.75
Today's RangeGBX 15.53 - GBX 16.90
52-Week RangeGBX 12.15 - GBX 29.25
Volume171,236 shs
Average Volume207,445 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Evgen Pharma plc, a clinical stage drug development company, focuses on the treatment of cancer and neurological diseases. Its core technology is Sulforadex, which include synthetic and stabilized analogues of the naturally occurring compound sulforaphane. The company's lead product is SFX-01, a synthetic version of sulforaphane stabilised that is in Phase II clinical trials for the treatment of breast cancer and subarachnoid haemorrhage, as well as in preclinical stage for multiple sclerosis and clinical stage to treat prostate cancer. Evgen Pharma plc was founded in 2007 and is headquartered in Wilmslow, the United Kingdom.

Receive EVG News and Ratings via Email

Sign-up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-151-7053532

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees11
Next Earnings DateN/A
OptionableNot Optionable

Evgen Pharma (LON:EVG) Frequently Asked Questions

What is Evgen Pharma's stock symbol?

Evgen Pharma trades on the London Stock Exchange (LON) under the ticker symbol "EVG."

What price target have analysts set for EVG?

1 Wall Street analysts have issued 1 year price objectives for Evgen Pharma's stock. Their forecasts range from GBX 113 to GBX 113. On average, they expect Evgen Pharma's share price to reach GBX 113 in the next year. This suggests a possible upside of 622.0% from the stock's current price. View Analyst Price Targets for Evgen Pharma.

What is the consensus analysts' recommendation for Evgen Pharma?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evgen Pharma in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Evgen Pharma.

Has Evgen Pharma been receiving favorable news coverage?

News headlines about EVG stock have been trending somewhat positive this week, InfoTrie reports. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Evgen Pharma earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future.

Who are some of Evgen Pharma's key competitors?

What other stocks do shareholders of Evgen Pharma own?

Who are Evgen Pharma's key executives?

Evgen Pharma's management team includes the folowing people:
  • Dr. Stephen Franklin, CEO & Exec. Director
  • Mr. Richard Anthony Moulson, CFO & Exec. Director (Age 57)
  • Sally Ross, Clinical Devel. Officer
  • Ms. Liz Jenkins, Regulatory Consultant
  • Dr. Thomas Morris, Consultant & Medical Advisor of Oncology

How do I buy shares of Evgen Pharma?

Shares of EVG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Evgen Pharma's stock price today?

One share of EVG stock can currently be purchased for approximately GBX 15.65.

What is Evgen Pharma's official website?

The official website for Evgen Pharma is http://evgen.com/.

How can I contact Evgen Pharma?

Evgen Pharma's mailing address is The Colony 146 Brownlow Hill, Altrincham Road, WILMSLOW, SK9 4LY, United Kingdom. The company can be reached via phone at +44-151-7053532.


MarketBeat Community Rating for Evgen Pharma (LON EVG)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  111 (Vote Underperform)
Total Votes:  271
MarketBeat's community ratings are surveys of what our community members think about Evgen Pharma and other stocks. Vote "Outperform" if you believe EVG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVG will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Beta

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel